VI Simposio Internacional de Genética Humana

Date: August 13, 2026 - August 15, 2026
Type: In-person
Location: LATAM
Areas of Interest: Exomes

We are excited to join the 26th ACGH Congress — Asociación Colombiana de Genética Humana, taking place August 13–15 in Pereira, Colombia. Join us and meet our LATAM team to learn how SOPHiA DDM™ helps clinical genetics laboratories across the region implement optimized, technology-agnostic genomic testing — from exome design to actionable diagnosis.

The SOPHiA GENETICS team is looking forward to seeing you at our sponsored academic breakfast talk.

Academic Breakfast Talk on Friday, August 14th, from 8:00 to 9:00 am — Salón 1, Genética Médica.

"From Design to Diagnosis: Implementation of Optimized Exomes in Clinical Practice"

Luna Rodríguez, MSc., Subject Matter Expert, SOPHiA GENETICS
Dr. Coztli Ocelotl Azotla, Geneticist, Genos Médica

In this talk, we will explore how optimized exome design is reshaping clinical genetics workflows across Latin America, bridging the gap between test design and real-world diagnostic impact.

Explore how optimized exome sequencing strategies improve diagnostic yield while streamlining laboratory workflows in clinical genetics.
Discover how a technology-agnostic platform like SOPHiA DDM™ enables laboratories of different sizes and infrastructures to implement standardized, scalable genomic testing.
Gain insights from real-world clinical experience on integrating optimized exomes into everyday diagnostic practice, supported by a case-based perspective from Genos Médica.

Come find us at booth #19 for expert discussions and collaborative opportunities.

Book a Meeting

URL

This field is for validation purposes and should be left unchanged.

First Name(Required)

Last Name(Required)

Organization(Required)

Job Title(Required)

Area of Interest(Required)

Email(Required)

Phone

Country(Required)

Select US State(Required)

Privacy Policy(Required)

By checking this box, I declare that I have read and accepted in full SOPHiA GENETICS privacy policy. The data provided herein is used to process your request. Click here for more information relating to our privacy policy

Marketing Opt-In

I agree to receive information from SOPHiA GENETICS about products, services, events and promotions. I understand I will be able unsubscribe by using the link integrated with the communication at any time.

3rd Party Opt-In

I agree that SOPHiA GENETICS may share my webinar registration details with 3rd parties, and that I may receive marketing communications from these 3rd parties. I understand that I can withdraw my consent at any time.

This field is hidden when viewing the form

Job Title/Industry(Required)

Disclaimer notice:
The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.
The opinions expressed during this presentation are these of the speaker and may not represent the opinions of SOPHiA GENETICS.
SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.

SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

SOPHiA DDM™ Overview

SOPHiA DDM™ for Genomics

SOPHiA DDM™ for Radiomics

SOPHiA DDM™ for Multimodal

Professional Services